Working… Menu

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (FALCON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03918447
Recruitment Status : Recruiting
First Posted : April 17, 2019
Last Update Posted : February 2, 2021
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : August 2023